Drugbank Logo

Search Results

Search for "Azathioprine" returned 7 results

Showing 1-7 out of 7
DrugBank ID Name Formula Weight
DB00993
DrugCard button for DB00993
Azathioprine C9H7N7O2S 277.2630
2265 9055 APRD00811 Azathioprin Azathioprine Sodium Azatioprin Azothioprine The oral LD<sub>50</sub> for single doses of azathioprine in mice and rats are 2500 mg/kg and 400 mg/kg, respectively ...
DB01024
DrugCard button for DB01024
Mycophenolic acid C17H20O6 320.3371
... and can be used in place of the older anti-proliferative azathioprine. It is usually used as part of triple therapy including a calcineurin inhibitor (ciclosporin or tacrolimus) and prednisolone.
DB00233
DrugCard button for DB00233
Aminosalicylic Acid C7H7NO3 153.1354
... BHA WUBBRNOQWQTFEX-KZFATGLACO For the treatment of tuberculosis Azathioprine The 5-ASA derivative increases the toxicity of thiopurine Mercaptopurine The 5-ASA derivative increases the ...
DB00437
DrugCard button for DB00437
Allopurinol C5H4N4O 136.1115
... Anisindione Allopurinol increases the anticoagulant effect Azathioprine Allopurinol increases the effect of thiopurine Cyclosporine Allopurinol increases the effect and toxicity of ...
DB00244
DrugCard button for DB00244
Mesalazine C7H7NO3 153.1354
Azathioprine The 5-ASA derivative increases the toxicity of thiopurine Mercaptopurine The 5-ASA derivative increases the toxicity of thiopurine Thioguanine The 5-ASA derivative increases the ...
DB00519
DrugCard button for DB00519
Trandolapril C24H34N2O5 430.5372
Monitor for increased toxic effects of Azathioprine if Trandolapril is initiated or dose increased. Bendroflumethiazide The thiazide diuretic, Bendroflumethiazide, may increase the hypotensive ...
DB00072
DrugCard button for DB00072
Trastuzumab C6470H10012N1726O2013S42 145531.5000
Monitor closely for signs and symptoms of adverse events. Azathioprine Trastuzumab may increase the risk of neutropenia and anemia. Monitor closely for signs and symptoms of adverse events.
Showing 1-7 out of 7

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.